Latest Medtech News
Whether you're a first-time founder with a device concept or a team ready to scale past FDA clearance, the right accelerator can compress years of trial and error into months. In an environment where mistakes and miscalculations can derail your progress, the right mentors can help you bridge engineering, clinical and business gaps you might not have even known existed. This is why we share six programs worth applying to right now, chosen for their genuine dedication to the invention, development, and deployment of innovative technology into HealthTech and MedTech.
Location: Los Angeles, USA (global program, plus a dedicated Asia Pacific track)
Equity taken: None
Notable alumni:
Nalu Medical (acquired by Boston Scientific for $600M)
Bardy Diagnostics (acquired by Hillrom for $375M cash + milestones)
AventaMed (acquired by KARL STORZ, undisclosed)
MindMaze Therapeutics (acquired by Relief Therapeutics)
The world's largest MedTech accelerator and the benchmark most others get compared to. The 2026 cohort selected 65 companies from 1,835 applicants, the top 3.5%, competing for a share of $800,000 in funding. Since launching in 2013, MedTech Innovator has supported over 800 startups that have collectively raised more than $12 billion in follow-on funding and achieved over 500 FDA authorizations. The four-month program culminates at The MedTech Conference in Boston each October, where companies get direct access to industry executives and investors. If you want maximum visibility in the device industry specifically, this one should be at the top of your list.
Location: Mountain View, California, USA (Silicon Valley)
Equity taken: None
Notable alumni:
nVision Medical (acquired by Boston Scientific for $275M)
PQ Bypass (acquired by Endologix for ~$300M)
HeartFlow (IPO, raised $364.2M gross)
Materna Medical (~$57.7M raised to date)
A nonprofit MedTech-specific incubator founded in the lineage of Dr. Thomas Fogarty, the cardiovascular device pioneer behind the embolectomy catheter. Fogarty Innovation is smaller and more specialized than others on this list, focused purely on advancing MedTech innovation from concept to clinical impact, with deep ties into the device engineering and venture communities around Stanford and Silicon Valley. The program is notable for the caliber of hands-on mentorship rather than program scale, and successful alumni frequently cross-apply to bigger accelerators as they grow.
3. JLABS (Johnson & Johnson Innovation)
Location: Global network, 10+ physical sites plus a virtual EMEA track
Equity taken: None
Notable alumni:
Qure.ai ($156.5M raised)
Laminar (acquired by J&J MedTech for $400M upfront + undisclosed milestones)
Respiree ($15.2M raised)
Calypso Biotech (acquired by Novartis for up to $425M)
J&J's "no-strings-attached" incubator is built for early-stage companies across MedTech, pharma, and health tech, with more than 1,240 member companies and residents to date, and over $173 billion in secured and contingent funding raised by its portfolio without J&J taking equity or IP rights. Residents typically stay around two years, with access to lab space, mentoring through the JPAL network, and connections into J&J's internal expertise on regulatory and manufacturing challenges most first-time founders haven't dealt with yet. If your device is still pre-clinical or early-stage and you need real lab infrastructure alongside mentorship, it is a strong fit.
4. Texas Medical Center Innovation, HealthTech Accelerator
Location: Houston, Texas, USA
Equity taken: None
Notable alumni:
Decisio Health (acquired by GE HealthCare Technologies, undisclosed)
Sensely (acquired by Mediktor, Undisclosed, all equity merger)
Dozee ($38.4M raised)
Based inside the world's largest medical center, this program (formerly branded TMCx) just ran its 19th cohort, selecting 11 MedTech startups spanning surgery, respiratory care, diagnostics, and women's health. Participants get direct access to TMC's member hospitals and clinical researchers, working through customer discovery and clinical validation before spending five months refining go-to-market plans with TMC specialists. The surrounding ecosystem also includes TMC Biodesign and the J&J Center for Device Innovation, making Houston one of the denser MedTech innovation hubs in the US if you can relocate for the program.
5. Mayo Clinic Platform_Accelerate
Location: Rochester, Minnesota
Equity taken: Yes, calculated relative to each startup's own valuation at the time
Notable alumni:
ScienceIO (acquired by Veradigm for $140M cash)
Cardiolife
MICA Medical
Mayo Clinic's accelerator leans heavily toward AI-driven and data-intensive healthcare technology, giving participants access to Mayo Clinic Platform's de-identified clinical data ecosystem, alongside one-on-one technical mentorship from Mayo clinicians and experts. Recent cohorts have run around 18 to 20 companies, with the most recent June 2026 group building tools spanning clinical decision support, oncology trial data, and cardiac diagnostics. If your product depends on validating an algorithm against real clinical data rather than building physical hardware, this is a stronger fit than the more device-heavy programs on this list.
Location: Philadelphia, USA (program runs across the US and Israel)
Equity taken: Yes, hybrid venture fund model, based on the company’s most recent valuation or a convertible note or SAFE
Notable alumni:
Tissue Analytics (acquired by Net Health, undisclosed)
NarrativeDx (acquired by Press Ganey, $18 million LBO / add-on acquisition)
Eko Health (~$195M raised total)
Regard (~$76–84M raised)
Dreamit runs three separate verticals: Healthtech, Securetech (cybersecurity), and Urbantech. Its Healthtech track focuses specifically on digital health, medical device, and diagnostics startups. Unlike most of the programs above, Dreamit isn't built for pre-product founders: it targets companies that already have a product and some early revenue or pilot traction, then works to help them scale through structured Customer Sprints (pitching to enterprise buyers like health systems, payers, and medical device manufacturers) and Investor Sprints. Portfolio alumni include Biomeme (molecular diagnostics), Eko Health (digital stethoscopes), and Tissue Analytics. If you're past the "does this work" stage and stuck on "how do we sell this to a hospital system," this is a better fit than the earlier-stage programs on this list.
These accelerators focus on different technologies and stages, so the right fit depends on where you and your company stand. Applying to more than one isn't unusual. Some device startups pass through Fogarty Innovation or TMC Biodesign early, then move to MedTech Innovator or JLABS once they have clinical traction. Whichever you choose, talk to founders, clinicians, and engineers who've already faced the many challenges that stand in your way.